Loading organizations...
Loading organizations...
Biotechnology company focused on viral therapies and treatments.
Immvira has raised $68.0M across 2 funding rounds.
Immvira has raised $68.0M in total across 2 funding rounds.
Immvira has raised $68.0M in total across 2 funding rounds.
Immvira's investors include Shanghai Healthcare Capital, Huagai Capital, Apricot Capital.
Immvira has raised $68.0M across 2 funding rounds. Most recently, it raised $10.0M Series B in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 24, 2020 | $10.0M Series B | Shanghai Healthcare Capital | |
| Jun 15, 2020 | $58.0M Series B | Huagai Capital | Apricot Capital |